natgillin/translations-raw huggingface dataset:
This medicinal product must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer’s solution, and should be administered as a single intravenous solution in a separate infusion line.
Zdravila ne smemo mešati z infuzijskimi raztopinami, ki vsebujejo kalcij ali druge dvovalentne katione, na primer z raztopino Ringerjevega laktata, in jo je treba dajati kot samostojno intravensko raztopino z ločenim infuzijskim sistemeom.
This medicinal product must not be mixed with calcium or other divalent cation-containing infusion solutions such as lactated Ringer’s solution, and should be administered as a single intravenous solution in a separate infusion line.
Zdravila ne smemo mešati z infuzijskimi raztopinami, ki vsebujejo kalcij ali druge dvovalentne katione, na primer z raztopino Ringerjevega laktata, in jo je treba dajati kot samostojno intravensko raztopino z ločenim infuzijskim sistemom.
This medicinal product must not be mixed with other medicinal products except those mentioned above.
Tega zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjena zgoraj.
This medicinal product must not be mixed with other medicinal products except those mentioned below (see “Reconstitution Procedure”).
Zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjena v nadaljevanju (glejte
This medicinal product must not be mixed with other medicinal products except those mentioned in 6.6 or 12.
To zdravilo se ne sme mešati z drugimi zdravili razen s tistimi, ki so navedena v poglavju 6.6 ali 12.
This medicinal product must not be mixed with other medicinal products except those mentioned in 6.6.
Zdravilo se ne sme mešati z drugimi zdravili, razen s tistimi, ki so omenjena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Cepiva ne smemo mešati z drugimi zdravili razen s tistimi, ki so navedena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Cepiva ne smemo mešati z drugimi zdravili razen s tistimi, ki so omenjena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Tega zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjeni v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Tega zdravila se ne sme mešati z drugimi zdravili, razen s tistimi, navedenimi v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Zdravila ne smemo mešati z drudimi zdravili razen s tistimi, ki so omenjena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so omenjena v poglavju 6.6
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Zdravilo se ne sme mešati z drugimi zdravili, razen tistimi, ki so omenjena v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. (content of accompanying solvent ampoule).
Zdravila ne smemo mešati z drugimi zdravili razen s tistimi, ki so omenjena v poglavju 6.6. (vsebnost priložene ampule z vehiklom).
This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. It must especially not be mixed with sodium chloride 9 mg/ml (0.9%) solution for injection because it has been demonstrated that chloride reduces the solubility of methylthioninium chloride.
Zdravila ne smemo mešati z drugimi zdravili, razen s tistimi, ki so navedena v poglavju 6.6. Zlasti se ga ne sme mešati z raztopino natrijevega klorida 9 mg/ml (0,9 %) za injiciranje, ker je bilo dokazano, da kloridni ioni zmanjšajo topnost metiltioninijevega klorida.
This medicinal product must not be mixed with other medicinal products or electrolytes except those mentioned in section 6.6.
Zdravila ne smemo mešati z drugimi zdravili ali elektroliti, razen s tistimi, ki so omenjeni v poglavju 6.6.
This medicinal product must not be mixed with other medicinal products than Humalog.
Zdravila ne smemo mešati z drugimi zdravili razen z zdravilom Humalog.
This medicinal product must not be mixed with other medicinal products than Liprolog.
Zdravila ne smemo mešati z drugimi zdravili razen z zdravilom Liprolog.
This medicinal product must not be mixed with other medicinal products, particularly with sodium chloride solutions.
Zdravilo se ne sme mešati z drugimi zdravili, predvsem z raztopinami natrijevega klorida
This medicinal product must not be mixed with other medicinal products.
Tega zdravila ne smemo mešati z drugimi zdravili.
This medicinal product must not be used in patients with hepatic impairment (see sections 4.3 and 5.2).
Tega zdravila se ne sme uporabljati pri bolnikih z okvaro jeter (glejte poglavji 4.3 in 5.2).
This medicinal product must not be used in patients with hepatic impairment (see sections 4.3, 4.4 and 5.2).
Pri bolnikih z okvaro jeter se tega zdravila ne sme uporabljati (glejte poglavja 4.3, 4.4 in 5.2).
This medicinal product must not be used in patients with hepatic impairment (see sections 4.3, 4.4 and 5.2).
Tega zdravila se ne sme uporabljati pri bolnikih z jetrno okvaro (glejte poglavja 4.3, 4.4 in 5.2).
This medicinal product must not be used in patients with moderate to severe renal impairment (see sections 4.3, 4.4 and 5.2).
Tega zdravila se ne sme uporabljati pri bolnikih z zmerno do hudo okvaro ledvic (glejte poglavja 4.3, 4.4 in 5.2).
This medicinal product should be administered as a single intravenous bolus injection, manually, or by magnetic resonance injector (MR injector) over a period of time up to 30 seconds followed by a 25- 30 ml normal saline flush.
Ta medicinski izdelek je treba odmerjati v obliki enkratne intravenske bolusne injekcije, ročno ali z injektorjem za MR (magnetno resonance) v času do 30 sekund, nato sledi izpiranje s 25-30 ml fiziološke raztopine.
This medicinal product should be administered by a healthcare professional and under appropriate medical supervision.
Zdravilo sme dajati samo strokovni zdravstveni delavec, sme pa se dajati samo pod ustreznim zdravniškim nadzorom.
This medicinal product should be administered by qualified healthcare professionals and under appropriate medical supervision.
Zdravilo lahko daje usposobljen zdravstveni delavec.
This medicinal product should be discarded if kept at room temperature for more than two weeks.
Če je bilo zdravilo shranjeno na sobni temperaturi več kot dva tedna, ga morate zavreči.
This medicinal product should be swallowed whole, preferably with water, with or without food.
To zdravilo je treba zaužiti celo, najbolje z vodo, s hrano ali brez nje.
This medicinal product should be visually inspected before use.
Pred uporabo je treba zdravilo vizualno pregledati.
This medicinal product should never be mixed with any other medicinal products.
Tega zdravila ne smete nikoli mešati z nobenim drugim zdravilom.
This medicinal product should not be given to children under 18 years of age because the safety and efficacy have not yet been fully established.
Tega zdravila ne smete dajati otrokom, mlajšim od 18 let, ker varnost in učinkovitost še nista bili popolnoma ugotovljeni.
This medicinal product should not be given to children under 18 years of agebecause the safety and efficacy have not yet been fully established.
Tega zdravila ne smete dajati otrokom, mlajšim od 18 let, ker varnost in učinkovitost še nista bili popolnoma ugotovljeni.
This medicinal product should only be used under the supervision of a doctor.
To zdravilo se sme jemati samo pod zdravniškim nadzorom.
This medicinal products contains less than 1 mmol potassium (39 mg) per dose, i.e. essentially ‘potassium-free’.
To cepivo vsebuje manj kot 1 mmol (39 mg) kalija na odmerek, kar v bistvu pomeni ”brez kalija”.
This medicine also contains sodium ascorbate and sodium chloride.
Zdravilo vsebuje tudi natrijev askorbat in natrijev klorid.
This medicine also contains sodium less than 1mmol sodium (0.035 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje tudi manj kot 1mmol (0,035 mg) natrija na odmerek, kar v bistvu pomeni "brez natrija".
This medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 °C for a single period of up to six months.
To zdravilo se lahko shranjuje tudi v originalni škatli izven hladilnika do največ 25 °C za enkratno obdobje do 6 mesecev.
This medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25°C for a single period of up to six months.
To zdravilo se lahko shranjuje tudi v originalni škatli izven hladilnika do največ 25 °C za enkratno obdobje do 6 mesecev.
This medicine can also be used to prevent fungal infections in adults who are at high risk of getting a fungal infection, such as: patients who have a weak immune system due to having chemotherapy for “acute myelogenous leukemia” (AML) or “myelodysplastic syndromes” (MDS) patients having “high-dose immunosuppressive therapy” after “hematopoietic stem cell transplant” (HSCT).
To zdravilo se lahko uporabi tudi za preprečevanje glivnih okužb pri odraslih, ki imajo veliko tveganje za takšne okužbe, na primer: pri bolnikih z oslabljenim imunskim sistemom zaradi kemoterapije, potrebne za zdravljenje akutne mieloične levkemije (AML) ali mielodisplastičnih sindromov (MDS); pri bolnikih, ki prejemajo visokoodmerno imunosupresijsko zdravljenje po presaditvi hematopoetskih matičnih celic (HSCT).
This medicine can be taken with or without food or drink.
To zdravilo lahko jemljete skupaj s hrano ali pijačo ali brez njiju.
This medicine can be taken with or without food or drink.
To zdravilo lahko jemljete skupaj s hrano ali pijačo ali brez.
This medicine can be used alone or together with an antidiabetic medicine called ‘sulphonylurea’ or together with insulin.
To zdravilo se lahko uporablja samostojno ali skupaj z antidiabetičnim zdravilom imenovanim »sulfonilsečnina« ali skupaj z insulinom.
This medicine can be used for can be used in a type of heart attacks called acute ST-segment elevation myocardial infarction (STEMI).
To zdravilo se lahko uporablja za zdravljenje srčne kapi, imenovane akutni miokardni infarkt z dvigom spojnice ST (STEMI).
This medicine can be used for can be used in a type of heart attacks called acute ST-segment elevationmyocardial infarction (STEMI).
To zdravilo se lahko uporablja za zdravljenje srčne kapi, imenovane akutni miokardni infarkt z dvigom spojnice ST (STEMI).
This medicine can cause allergic reactions such as hives, swelling of the tongue and lips, diarrhoea, nausea, tiredness and itching.
To zdravilo lahko povzroči alergijske reakcije, na primer koprivnico, otekanje jezika in ustnic, drisko, siljenje na bruhanje, utrujenost in srbenje.
This medicine can cause dizziness.
Zdravilo lahko povzroči omotico.
This medicine can increase the amount of rilpivirine and tenofovir alafenamide (components of Odefsey) in your blood.
Ta učinkovina lahko poveča količino rilpivirina in alafenamidtenofovirata (sestavini zdravila Odefsey) v krvi.
This medicine can increase the risk of bleeding or increase the risk of problems with wound healing after surgery.
to zdravilo lahko poveča tveganje za krvavitve ali poveča tveganje za težave pri celjenju ran po operaciji.
This medicine can only be obtained by ‘special’ prescription.
Izdaja zdravila je le na „poseben“ recept.
This medicine can only be obtained with a prescription.
Izdaja zdravila je le na recept.
This medicine can reduce the effect of medicines against Parkinson’s disease and restless legs syndrome (e.g. levodopa).
To zdravilo lahko zmanjša učinke zdravil za zdravljenje Parkinsonove bolezni in sindroma nemirnih nog (npr. levodope).
This medicine can reduce the effect of medicines against Parkinson’s disease and restless legs syndrome (e.g., levodopa).
To zdravilo lahko zmanjša učinke zdravil za zdravljenje Parkinsonove bolezni in sindroma nemirnih nog (npr. levodope).
This medicine consists of white coated granules.
To zdravilo so bela obložena zrnca.
This medicine contains
To zdravilo vsebuje
This medicine contains 0.11 mg sodium per 250 mg sachet and 0.22 mg sodium per 500 mg sachet.
To zdravilo vsebuje 0,11 mg natrija na 250 mg vrečko in 0,22 mg natrija na 500 mg vrečko.
This medicine contains 0.150 mmol sodium (which is 3.45 mg sodium) per mL of concentrate.
To zdravilo vsebuje 0,150 mmol natrija (kar ustreza 3,45 mg natrija) na ml koncentrata.
This medicine contains 0.16 mg sodium per 250 mg capsule and 0.32 mg sodium per 500 mg capsule.
To zdravilo vsebuje 0,16 mg natrija na 250 mg kapsulo in 0,32 mg natrija na 500 mg kapsulo.
This medicine contains 0.29 mmol sodium per vial.
To zdravilo vsebuje 0,29 mmol natrija na vialo.
This medicine contains 0.482 mmol sodium (or 11.1 mg) per vial.
To zdravilo vsebuje 0,482 mmol natrija (ali 11,1 mg) na vialo.
This medicine contains 1.5 mmol (or 34.5 mg) sodium per maximum dose of 4 vials (0.375 mmol or 8.625 mg sodium per vial).
To zdravilo vsebuje 1,5 mmol (ali 34,5 mg) natrija na največji odmerek 4 viale (0,375 mmol ali 8,625 mg natrija na vialo).
This medicine contains 1.9 mg sodium per ml of reconstituted solution.
To zdravilo vsebuje približno 1,9 mg natrija na ml rekonstituirane raztopine.
This medicine contains 10.0 mmol (230 mg) of sodium per vial.
Zdravilo vsebuje 10,0 mmol (230 mg) natrija na vialo.
This medicine contains 108 mg sodium per vial.
To zdravilo vsebuje 108 mg natrija v eni viali.
This medicine contains 146 mg sodium in each 50 mL vial.
Vsaka 50-ml viala zdravila vsebuje 146 mg natrija.
This medicine contains 2.4 mmol sodium per vial.
To zdravilo vsebuje 2,4 mmol natrija na vialo.
This medicine contains 2.427 mmol (or 55.8 mg) of sodium per daily dose (4 tablets).
To zdravilo vsebuje 2,427 mmol (ali 55,8 mg) natrija na dnevni odmerek (4 tablete).
This medicine contains 244 mg sodium per dose.
To zdravilo vsebuje 244 mg natrija na odmerek.
This medicine contains 26.55 mg sodium per maximum dose of 1200 mg.
To zdravilo vsebuje 26,55 mg natrija na največji odmerek 1200 mg.
This medicine contains 28 mg sodium (7 mg/ml) after it has been reconstituted.
To zdravilo po pripravi vsebuje 28 mg (7 mg/ml) natrija .
This medicine contains 36 mg of sodium per dose which should be taken into consideration by patients on a controlled sodium diet.
To zdravilo vsebuje 36 mg natrija na odmerek, kar morajo upoštevati bolniki, ki so na dieti z nadzorovanim vnosom natrija.
This medicine contains 4.4 mg sodium per milliliter once it is made up.
Zdravilo po pripravi vsebuje 4,4 mg natrija na mililiter.
This medicine contains 50 mg sodium per dose.
To zdravilo vsebuje 50 mg natrija na odmerek.
This medicine contains 50 vol % ethanol anhydrous (alcohol), i.e. up to 1580 mg ethanol anyhdrous per 4 ml vial, equivalent to 40 ml of beer or 17 ml wine per 4 ml vial,
To zdravilo vsebuje 50 vol. % brezvodnega etanola (alkohola), to je do 1580 mg brezvodnega etanola na 4 ml vialo, kar ustreza 40 ml piva oziroma 17 ml vina na 4 ml vialo.
This medicine contains 50 vol % ethanol anhydrous (alcohol), i.e. up to 2370 mg ethanol anhydrous per 6 ml vial, equivalent to 60 ml of beer or 25 ml wine per 6 ml vial.
To zdravilo vsebuje 50 vol. % brezvodnega etanola (alkohola), to je do 2370 mg brezvodnega etanola na 6 ml vialo, kar ustreza 60 ml piva oziroma 25 ml vina na 6 ml vialo.
This medicine contains 50 vol % ethanol anhydrous (alcohol), i.e. up to 2765 mg ethanol anhydrous per 7 ml vial, equivalent to 70 ml of beer or 29 ml wine per 7 ml vial.
To zdravilo vsebuje 50 vol. % brezvodnega etanola (alkohola), to je do 2765 mg brezvodnega etanola na 7 ml vialo, kar ustreza 70 ml piva oziroma 29 ml vina na 7 ml vialo.
This medicine contains 50 vol % ethanol anhydrous (alcohol), i.e. up to 3160 mg ethanol anhydrous per 8 ml vial, equivalent to 80 ml of beer or 33 ml wine per 8 ml vial.
To zdravilo vsebuje 50 vol. % brezvodnega etanola (alkohola), to je do 3160 mg brezvodnega etanola na 8 ml vialo, kar ustreza 80 ml piva oziroma 33 ml vina na 8 ml vialo.
This medicine contains 50 vol % ethanol anhydrous (alcohol), i.e. up to 395mg ethanol anhydrous per 1 ml, equivalent to 10 ml of beer or 4 ml wine per 1 ml vial.
To zdravilo vsebuje 50 vol. % brezvodnega etanola (alkohola), to je do 395 mg brezvodnega etanola na 1 ml vialo, kar ustreza 10 ml piva ali 4 ml vina na 1 ml vialo.
This medicine contains 54 mg sodium per vial.
To zdravilo vsebuje 54 mg natrija v eni viali.
This medicine contains 6.3 mmol sodium (or 145 mg) per dose.
To zdravilo vsebuje 6,3 mmol (ali 145 mg) natrija na odmerek.
This medicine contains 6.4 mg sodium per vial after preparation.
Pripravljeno zdravilo vsebuje 6,4 mg natrija na vialo.
This medicine contains a colorant called sunset yellow (E110), which may cause allergic reactions.
To zdravilo Pradaxa vsebuje barvilo, imenovano sončno rumeno FCF (E110), ki lahko povzroči alergijske reakcije.
This medicine contains a colorant called sunset yellow (E110), which may cause allergic reactions.
To zdravilo vsebuje barvilo, imenovano sončno rumeno FCF (E110), ki lahko povzroči alergijske reakcije.
This medicine contains anhydrous lactose.
Zdravilo vsebuje brezvodno laktozo.
This medicine contains aspartame, which is a source of phenylalanine.
Zdravilo vsebuje sladilo aspartam, ki je izvor fenilalanina.
This medicine contains cetostearyl alcohol and stearyl alcohol which may cause local skin reactions (e.g. contact dermatitis).
To zdravilo vsebuje cetil in stearilalkohol in stearilalkohol, ki lahko povzroči lokalne reakcije na koži (npr. kontaktni dermatitis).
This medicine contains lactose (as monohydrate), sucrose, glucose (in polydextrose and maltitol liquid) and sorbitol (in polydextrose) (types of sugars).
To zdravilo vsebuje laktozo (v obliki monohidrata), saharozo, glukozo (v obliki polidekstroze in tekočega maltitola) in sorbitol (v obliki polidekstroze) (vrste sladkorja).
This medicine contains lactose monohydrate.
To zdravilo vsebuje laktozo monohidrat.
This medicine contains less than 1 mg of sodium per dose i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mg natrija na odmerek, kar v bistvu pomeni 'brez natrija'.
This medicine contains less than 1 mmol (23 mg) of sodium per dose which means it is essentially “sodium-free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni 'brez natrija'.
This medicine contains less than 1 mmol (23 mg) of sodium per dose which means it is essentially “sodium-free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ’brez natrija'.
This medicine contains less than 1 mmol (23 mg) sodium per dose, and is therefore considered essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni brez natrija.
This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ´brez natrija´.
This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek; to pomeni, da je praktično "brez natrija".
This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
This medicine contains less than 1 mmol (23 mg) sodium per dose.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek.
This medicine contains less than 1 mmol (23 mg) sodium per maximum dose (two 12 mg packs), i.e. it is essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na največji odmerek (dve 12-miligramski pakiranji), kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol (23 mg) sodium per tablet, i.e. essentially “sodium-free”.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na tablet, kar v bistvu pomeni 'brez natrija'.
This medicine contains less than 1 mmol potassium (39 mg) per infusion, i.e. it is essentially ‘potassium- free’.
To zdravilo vsebuje manj kot 1 mmol kalija (39 mg) na infuzijo, kar v bistvu pomeni „brez kalija“.
This medicine contains less than 1 mmol sodium (23 mg) per 0.5 ml dose, so is essentially ‘sodium free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 0,5-ml odmerek; to pomeni, da je praktično "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per 100 mg dose, i.e. essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 100 mg, kar v bistvu pomeni „brez natrija“.
This medicine contains less than 1 mmol sodium (23 mg) per 100 ml, i.e. essentially “sodium –free.”
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 100 ml, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per 100 ml, i.e. essentially “sodium-free.”
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 100 ml, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per 100 ml; i.e. essentially “sodium –free.”
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 100 ml, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per 100 ml; i.e. essentially “sodium-free.”
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na 100 ml, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per 60 mg, i.e. essentially ‘sodium-free’.
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na 60 mg, kar pomeni, da je praktično "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per capsule, i.e. essentially ‘sodium free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na kapsulo, kar v bistvu pomeni »brez natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per dose i.e., essentially “sodium free.”
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per dose i.e., essentially “sodium-free.”
Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar pomeni, da praktično »ne vsebuje natrija«.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially 'sodium-free'.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni “brez natrija”.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium- free’
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni ʽbrez natrijaʼ.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium- free’
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium- free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo v sebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni »brez natrija«
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni "brez natrija".
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar v bistvu pomeni ´brez natrija´.